This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Kracie Pharma, Ltd., National Cancer Center, The University of Toyama. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Toyama, JP (2015)
- Takaoka, JP (2017)
Company Filing History:


Years Active: 2015-2017
Title: Takafumi Fuse: Innovator in Anti-Cancer Research
Introduction
Takafumi Fuse is a distinguished inventor based in Takaoka, Japan, known for his significant contributions to medical innovations, particularly in the field of oncology. With a total of two patents under his name, Fuse's work revolves around developing effective anti-cancer agents derived from natural sources.
Latest Patents
Takafumi Fuse's latest patents focus on novel anticancer agents. One of these inventions provides a new approach to treating cancer using burdock fruit extract, specifically a compound called arctigenin. This innovation highlights the observed tumor-reducing effects after administering a daily dose of 100 mg or more of arctigenin to pancreas cancer patients. Furthermore, the invention emphasizes the formulation of an anticancer agent containing both arctigenin and arctiin at a specified weight ratio of 0.7 to 1.3.
Additionally, Fuse's second patent details a method for producing a burdock fruit extract that equilibrates arctigenin and arctiin at approximately a 1:1 ratio. This method involves cutting the burdock fruit and performing enzymatic conversion of arctiin into arctigenin, utilizing beta-glucosidase present in the fruit, under controlled temperature conditions ranging from 20°C to 50°C. The extraction process includes the use of an organic solvent and heating to facilitate the recovery of the beneficial compounds.
Career Highlights
Throughout his career, Takafumi Fuse has been associated with reputable institutions such as the University of Toyama and Kracie Pharma, Ltd., where he has conducted extensive research in his field. His work has garnered attention due to its potential implications for cancer treatment and patient care.
Collaborations
In his innovative journey, Fuse has collaborated with esteemed colleagues, including Toshiki Okubo and Satoshi Yomoda. These collaborations have been instrumental in advancing research objectives and promoting the development of effective cancer therapies.
Conclusion
Takafumi Fuse's inventive spirit and dedication to oncology exemplify the impact that innovative research can have on healthcare. His patented inventions not only reflect his expertise but also contribute significantly to the ongoing battle against cancer, paving the way for future advancements in treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile